Charmacy Pharmaceutical (2289) Proposes Auditor Change

Bulletin Express

Nov 06, 2025

Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) announced a proposed change of auditors in line with regulations that generally limit the continuous service of an accounting firm to no more than eight years. The existing auditor, ShineWing, which has served the company since 2017, will resign at the conclusion of the forthcoming extraordinary general meeting.

According to the announcement, ShineWing has confirmed in writing that there are no matters requiring the attention of shareholders, and there is no disagreement between the company and the outgoing auditor. The board of directors stated that the change will not materially affect the annual audit for the year ending December 31, 2025.

Charmacy Pharmaceutical intends to appoint Pan-China Certified Public Accountants LLP as the new auditor, subject to shareholder approval. The board and the audit committee concluded that Pan-China’s industry experience, resource capability, and familiarity with relevant accounting standards make it a suitable choice to continue providing audit services for the company’s upcoming financial statements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1161460942"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1161460942\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1161460942?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-06 16:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161460942","market":"us","top_or_hot":-1,"title":"Charmacy Pharmaceutical (2289) Proposes Auditor Change","media":"Bulletin Express","content":"<p>Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) announced a proposed change of auditors in line with regulations that generally limit the continuous service of an accounting firm to no more than eight years. The existing auditor, ShineWing, which has served the company since 2017, will resign at the conclusion of the forthcoming extraordinary general meeting.</p>\n<p>According to the announcement, ShineWing has confirmed in writing that there are no matters requiring the attention of shareholders, and there is no disagreement between the company and the outgoing auditor. The board of directors stated that the change will not materially affect the annual audit for the year ending December 31, 2025.</p>\n<p>Charmacy Pharmaceutical intends to appoint Pan-China Certified Public Accountants LLP as the new auditor, subject to shareholder approval. The board and the audit committee concluded that Pan-China’s industry experience, resource capability, and familiarity with relevant accounting standards make it a suitable choice to continue providing audit services for the company’s upcoming financial statements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Charmacy Pharmaceutical (2289) Proposes Auditor Change</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCharmacy Pharmaceutical (2289) Proposes Auditor Change\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-06 16:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) announced a proposed change of auditors in line with regulations that generally limit the continuous service of an accounting firm to no more than eight years. The existing auditor, ShineWing, which has served the company since 2017, will resign at the conclusion of the forthcoming extraordinary general meeting.</p>\n<p>According to the announcement, ShineWing has confirmed in writing that there are no matters requiring the attention of shareholders, and there is no disagreement between the company and the outgoing auditor. The board of directors stated that the change will not materially affect the annual audit for the year ending December 31, 2025.</p>\n<p>Charmacy Pharmaceutical intends to appoint Pan-China Certified Public Accountants LLP as the new auditor, subject to shareholder approval. The board and the audit committee concluded that Pan-China’s industry experience, resource capability, and familiarity with relevant accounting standards make it a suitable choice to continue providing audit services for the company’s upcoming financial statements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02289","symbol_name":"创美药业","start_time":0,"source_url":"","article_id":"1161460942","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161460942","pubTimestamp":1762418572,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) announced a proposed change of auditors in line with regulations that generally limit the continuous service of an accounting firm to no more than...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02289":"创美药业"},"translate_title":"Charmacy Pharmaceutical(2289)提议更换审计师","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02289":1},"content_text":"Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) announced a proposed change of auditors in line with regulations that generally limit the continuous service of an accounting firm to no more than eight years. The existing auditor, ShineWing, which has served the company since 2017, will resign at the conclusion of the forthcoming extraordinary general meeting.\nAccording to the announcement, ShineWing has confirmed in writing that there are no matters requiring the attention of shareholders, and there is no disagreement between the company and the outgoing auditor. The board of directors stated that the change will not materially affect the annual audit for the year ending December 31, 2025.\nCharmacy Pharmaceutical intends to appoint Pan-China Certified Public Accountants LLP as the new auditor, subject to shareholder approval. The board and the audit committee concluded that Pan-China’s industry experience, resource capability, and familiarity with relevant accounting standards make it a suitable choice to continue providing audit services for the company’s upcoming financial statements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}